文献速递脑血管病

新生儿炎症标志物与围产期卒中亚型的关联

Association of neonatal inflammatory markers and perinatal stroke subtypes.
PubMed 文献 · Neurology · 2020-07-29

本研究采用系统生物学方法分析47例患者的血清与血斑细胞因子,纳入197名参与者(NAIS 27例、APPIS 8例、PVI 12例、对照150例)。线性判别分析显示细胞因子谱可高准确度区分特定围产期卒中亚型与对照,NAIS分离灵敏度77%、特异度97%,APPIS与NAIS区分灵敏度86%、特异度99%。结论提示独特炎症生物标志物特征与特定围产期卒中疾病相关,支持获得性病理生理机制。

要点

  • 新生儿急性血清细胞因子谱可区分特定围产期卒中疾病与对照。
  • NAIS判别灵敏度77%、特异度97%;APPIS与NAIS区分灵敏度86%、特异度99%。
  • PVI患者细胞因子谱与对照相似,提示不同卒中亚型炎症机制不同。

核心结论

  • 独特炎症生物标志物特征与特定围产期卒中疾病相关,支持获得性病理生理机制,并提示可能识别高危妊娠以制定预防策略。

研究设计与样本

  • 基于人群的对照队列研究,前瞻性与回顾性病例确认,通过Alberta围产期卒中项目招募。
  • 共分析197名参与者:NAIS 27例、APPIS 8例、PVI 12例、对照150例,对照孕龄与母龄相当。

主要发现

  • 线性判别分析利用细胞因子谱区分组别具有高准确度。
  • PVI与对照的细胞因子谱相似。
  • NAIS分离准确(灵敏度77%,特异度97%)。
  • APPIS与NAIS区分可辨别(灵敏度86%,特异度99%)。
  • 分类树分析产生相似的诊断准确度。

关键数值与推荐

  • NAIS判别:灵敏度77%,特异度97%。
  • APPIS与NAIS区分:灵敏度86%,特异度99%。
  • 证据等级:Class III,表明急性新生儿血清细胞因子谱差异可区分特定围产期卒中疾病与对照。

临床怎么用

  • 新生儿急性血清细胞因子谱有潜力辅助区分特定围产期卒中亚型与对照。
  • PVI与对照细胞因子谱相似,提示其炎症特征不同于动脉性卒中。

局限性

  • 证据等级为Class III。
  • 样本中APPIS 8例、PVI 12例,亚型样本量较小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the relationship between neonatal inflammatory cytokines and perinatal stroke using a systems biology approach analyzing serum and blood-spot cytokines from 47 patients. METHODS: This was a population-based, controlled cohort study with prospective and retrospective case ascertainment. Participants were recruited through the Alberta Perinatal Stroke Project. Stroke was classified as neonatal arterial ischemic stroke (NAIS), arterial presumed perinatal ischemic stroke (APPIS), or periventricular venous infarction (PVI). Biosamples were stored blood spots (retrospective) and acute serum (prospective). Controls had comparable gestational and maternal ages. Sixty-five cytokines were measured (Luminex). Hierarchical clustering analysis was performed to create heat maps. The Fisher linear discriminant analysis was used to create projection models to determine discriminatory boundaries between stroke types and controls. RESULTS: A total of 197 participants were analyzed (27 with NAIS, 8 with APPIS, 12 with PVI, 150 controls). Cytokines were quantifiable with quality control measures satisfied (standards testing, decay analysis). Linear discriminant analysis had high accuracy in using cytokine profiles to separate groups. Profiles in participants with PVI and controls were similar. NAIS separation was accurate (sensitivity 77%, specificity 97%). APPIS mapping was also distinguishable from NAIS (sensitivity 86%, specificity 99%). Classification tree analysis generated similar diagnostic accuracy. CONCLUSIONS: Unique inflammatory biomarker signatures are associated with specific perinatal stroke diseases. Findings support an acquired pathophysiology and suggest the possibility that at-risk pregnancies might be identified to develop prevention strategies. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that differences in acute neonatal serum cytokine profiles can discriminate between patients with specific perinatal stroke diseases and controls.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mineyko A, Nettel-Aguirre A, de Jesus P, et al. Association of neonatal inflammatory markers and perinatal stroke subtypes. Neurology. 2020. PMID: 32727836. doi:10.1212/WNL.0000000000010309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。